Science brief
Accelerated Global Warming & Gene Editing Inquiry
Potsdam data confirms a post-2015 climate acceleration, while Nature probes an undisclosed patient death in China.
Science
Undisclosed patient deaths in preclinical submissions reveal deep gaps in how major academic journals verify foreign clinical data before publication.
BackgroundAcademic publishers expect preclinical papers to disclose any associated human trials or fatal adverse events before publishing novel therapy models. Omitting human trials undermines scientific peer review and blinds global regulators to early safety risks in biotechnology research.
- Nature attached an Editor's Note and opened a formal probe into a February 2026 gene therapy paper from Shanghai Jiao Tong University.
- Reporting revealed a six-year-old patient died seven days after receiving an experimental treatment for Snijders Blok-Campeau syndrome in an unmonitored human trial.
- Journal editors confirmed the paper submitted by researcher Zilong Qiu omitted all clinical testing details, hiding fatal adverse events from peer reviewers.
Science
Global warming has broken past its historic trendline to proceed at nearly double its pre-2015 speed — forcing carbon budgets to adjust to a steeper trajectory.
BackgroundClimate scientists long debated whether recent record temperatures stemmed from temporary El Niño events or a fundamental shift in Earth's warming trajectory. Separating human-driven baseline warming from natural ocean and solar cycles required multi-dataset statistical modeling across five independent global temperature records.
- Potsdam researchers isolated natural solar and volcanic oscillations, verifying that underlying global warming accelerated independent of short-term weather anomalies like El Niño.
- The detected underlying warming rate rose to ~0.35°C per decade over the last 10 years, compared to ~0.2°C per decade between 1970 and 2015, doubling historic trendlines.
- Statistical confirmation across five independent global temperature datasets yielded over 98% certainty, leaving little room for natural-cycle counterarguments.
Unlock the full brief
Sign in to read every signal, takeaway, and source. Free account — Apple, Google, or email.